Retrospective Analysis Study Shows CentrosFLO® Long-Term Hemodialysis Catheter Tip Design Offers Greater Patency

centrocaths

The Merit Medical CentrosFLO long-term hemodialysis catheter’s self-centering split-tip design has a greater separation between the arterial and venous tips than the symmetric-tip designed catheter. Its design is intended to optimize catheter patency and reduce fibrin sheath formation, thrombosis and vessel wall occlusions by keeping the tips of the catheter centered in the vessel and away from the vessel wall.

In May of 2013, a retrospective study was completed by Dr. Saravanan Balamuthusamy (“Dr. Bala”) at Angiocare, Vascular and Interventional Nephrology, in Tucson, Arizona. The performance and safety of a new self-centering, split tip hemodialysis tunneled catheter was compared with a symmetric-tip catheter in 58 patients.

Study Conclusion1
The study results indicated that the CentrosFLO self-centering, split-tip catheter had statistically greater patency after 3 months with similar clearance and blood flow.

Self-Centering,
Split-Tip Design
(n = 38)
Symmetric-Tip
Design
(n = 20)
Statistical
Probability
Patency 94.7% 75.0% P = 0.04
Mean Clearance (Kt/V)2 1.483 1.423 NSD4 (p = 0.48)
Mean Blood Flow (ml/min)2 393.93 381.63 NSD4 (p = 0.27)

1 Study data on file.
2 Mean value during the three-month follow-up period.
3 Mean clearance and mean blood flow did not include data from patients with no catheter patency.
4 NSD = Not Statistically Significant, p > 0.05 (t-tests).

For a full published version of this study, contact your local Merit Sales Representative.

Nate Smith – Senior Product Manager
Merit Medical Systems, Inc.

New! 7.5F ReSolve® Locking and Non-Locking Drainage Catheter

We are now pleased to offer the ReSolve® Locking and Non-Locking Drainage Catheters in 7.5F. These catheters are indicated for percutaneous drainage of fluid from body cavities. Some of the drainage procedures performed with these catheters are abscess, nephrostomy and cyst.

For many fluid collections, a 6.5F catheter is often too small to drain the fluid, but an 8.5F catheter is too large for the patient. These new catheters are great for those fluid collections and patients where an in-between catheter is needed.

These catheters continue to offer

  • Smooth transitions
  • Large drainage holes
  • Hydrophilic coating
  • Kink resistance

For more product information on Merit’s Drainage Products, visit https://www.merit.com/products/default.aspx?code=drainage.

Uterine Fibroid Embolization

Ask4UFE Website Revamped

ask4UFE uterine fibroids education campaign websiteFor more than a decade, the Ask4UFE patient education campaign has been an invaluable resource for the many women who suffer from symptomatic uterine fibroids. Our campaign has educated hundreds of women and empowered them to become more involved in the decision-making process for treating uterine fibroids. Our campaign provides women who suffer from fibroids with information on all the available treatment options.

We are more impassioned than ever to help raise the awareness level around fibroids and all available treatment options. The revamp of our website, ask4ufe.com, is a huge milestone for us and represents the rebirth of our awareness campaign.

Help us raise the awareness level about uterine fibroids and don’t forget to Ask4UFE!

Sincerely,
Your friends at Ask4UFE

Merit Medical’s Safeguard® Allows Parents to Hold Their Babies After Heart Surgery

I have a grandson that is 20 months old and who is in perpetual motion. If he’s awake, his inquiring mind has him looking, touching and listening to everything. Recently he injured his hand, pinching it in a door. It wasn’t serious, but all of a sudden he went from running around his playroom, to wanting to be held by his mother. It was as if it didn’t hurt if she was holding him.

In reflecting on this, I think of children who undergo a diagnostic or interventional cardiology procedure in the Pediatric Cath Lab, such as septal defects (ASDs or VSDs) or valve defects, such as pulmonary valve stenosis, among others. When the procedure is finished and they are in recovery, these young patients have the same desire to be held that my grandson exhibited. Merit Medical’s Safeguard Pressure Assisted Device gives children the ability to be held by their parents after heart surgery.

In an article in the November 2006 issue of Cath Lab Digest, Jill Dykstra, RN and Kathy Laird, RN with the Congenital Heart Institute at the Arnold Palmer Hospital for Children, in Orlando, Florida authored an article titled, Use of the Safeguard Pressure-Assisted Dressing for Patients Less than 15 kg Following Cardiac Catheterization. In it they stated: “…Prior to implementation of the Safeguard hemostasis device, methods for maintaining hemostasis included pressure dressings that did not allow for the parents to hold the infant…”

This 6-month study found that “…the Safeguard device does not restrict mobility and allows for parental contact immediately post-procedure.

The Safeguard gives clinical personnel a pressure assisted device that promotes hemostasis, decreases occurrences of re-bleeds, and most important, gives a child the comfort of being in the arms of a parent.

For more information regarding Safeguard and Merit’s comprehensive line of products for promoting hemostasis, visit merit.com.

Mark Heninger
Senior Product Manager

Merit Medical Opens Office in Bangalore, India

Merit Medical Systems is expanding with a new office in Bangalore, India.

image1-16

This new location will allow Merit to take advantage of the growing Indian healthcare market.
The key reason for opening an office to serve the Indian market is the large need that has been generated for our products over the last 3-5 years.

image2-18Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures in several disciplines including cardiology, radiology, nephrology, vascular surgery, electrophysiology, and endoscopy. Merit Medical has several therapeutic products to help clinicians treat patients suffering from uterine fibroids, tumors, end stage renal disease, strictures of the airway, and blood clots. Our therapeutic products include devices and accessories used to support the implantation of pacemakers and the treatment of irregular heartbeats.

Merit Medical Systems India Pvt Ltd is located at the following address:
206-207, HM Geneva House
14 Cunningham Road
Bangalore- 560052, INDIA
Phone: +91-80-41223378
Fax: 91-80-41223365

The office will be used for sales and marketing operations in the region.

Merit Medical EP Group Announces Launch of HeartSpan® Steerable Sheath Introducer

Merit Medical continues to add to its extensive line of products for Electrophysiology. The HeartSpan Steerable Sheath Introducer offers control, coverage and comfort for Electrophysiologists when navigating cardiac chambers. The 8.5F HeartSpan Steerable Sheath Introducer’s braided construction provides kink resistance and curve durability. The distal tapered tip creates a smooth transition from the dilator to sheath introducer to reduce trauma to the atrial septum.

image1-16CONTROL 

  • Softer, flexible tip
  • Smooth transition from dilator
  • Responsive curve deflection
  • Braided construction for kink resistance

COVERAGE 

  • Bidirectional (180-degree) deflection
  • Small curl (16.4 mm)
  • Medium curl (22.4 mm)
  • Large curl (36.0 mm)

COMFORT 

  • Ergonomic shape
  • Improved grip size

The HeartSpan line of products also includes the HeartSpan® Fixed Curve Braided Transseptal Sheath with braided steel shaft for excellent torqueability and the HeartSpan® Transseptal Needle designed to be exceptionally responsive with enhanced stiffness.

Our EP team is excited to introduce this new steerable sheath designed to help EPs extend their options.

Merit Medical’s ConcierGE® Has Better Kink Resistance and 1:1 Torque Than Leading Guiding Catheter Brands

THE BAR HAS BEEN RAISED by Merit Medical with the introduction of the Merit ConcierGE Guiding Excellence Catheter.

In an independent survey, approximately 40% on Interventional Cardiologists indicated that their current guiding catheter does not meet their needs for kink resistance.

Designed in 5F, 6F, 7F, and 8F, ConcierGE is the first guiding catheter designed with a higher level of guiding excellence.

Kink Resistance
kink-graph
The ConcierGE has approximately
30% more kink resistance*
than the leading brands, facilitating
the advancement and withdrawal of
interventional devices.
1:1 Torque
torque-graph
The ConcierGE test results prove
that it has better 1:1 torque
response** than the leading
brands, promoting quicker catheter
seating with less whipping.*

Each feature of the guiding catheter is designed to give you added confidence in difficult cases by optimizing clinical benefits without compromise during coronary angioplasty.

To learn more about how Merit has raised the bar for guiding catheter performance, read the ConcierGE Brochure or watch the ConcierGE Guiding Catheter product video.

Tami Anderson,
Senior Product Manager

New Studies Highlight Benefits Of STAR Tumor Ablation System For Patients With Spinal Tumors

San Jose, Calif. – Feb. 18, 2014 –Two studies presented at the American Society of Spine Radiology (ASSR) 2014 Annual Symposium in Miami highlighted the benefits of Targeted Radiofrequency Ablation™ (t-RFA) therapy with the DFINE STAR™ Tumor Ablation System. The studies demonstrated the ability of the STAR System to provide significant pain relief to patients suffering from painful spinal metatases; in many cases, these patients had not responded to standard therapies, such as radiation or chemotherapy. The first study, conducted by Bassem Georgy, M.D., Assistant Clinical Professor of Radiology at the University of California, San Diego, noted improvement in pain and functional status (quality of life) in all patients. The study also concluded that the targeted and minimally invasive nature of the STAR System allowed treatment of all of the studied tumors regardless of their location. The second study, conducted by Jack Jennings, M.D., PhD, Director of Musculoskeletal and Spine Interventions at the Mallinckrodt Institute of Radiology in St. Louis, demonstrated the value of the STAR System in treating patients who were not responsive to other standard treatments and who had tumors very close to the spinal cord (posterior lesions). In addition to relieving pain, the study concluded that the STAR System had successfully destroyed the lesions, and that in many patients no regrowth was observed during the study period.< “We are pleased with the continued success of STAR in providing pain relief to the many cancer patients suffering from spinal tumors,” said Greg Barrett, Chief Executive Officer of DFINE. “The therapy continues to gain momentum and we are gratified to see more clinicians embracing the technology to help their patients.” About STAR™ Tumor Ablation System The STAR Tumor Ablation System does not treat cancer. It was cleared by the FDA in 2010 for providing palliative treatment (e.g., pain relief) by ablation of metastatic malignant tumors in a vertebral body. With its use of targeted radiofrequency (RF) energy, the STAR System enables physicians to achieve pain relief through the use of a single, minimally invasive procedure that may be compatible with both chemo and radiation therapy. As with all surgical procedures, there are risks and contraindications associated with the STAR System which are described in the product labeling.  The STAR System is available at more than 200 institutions in the U.S. For more information regarding spinal tumors or to find a physician, visit http://www.spine-tumors.com. About STAR™ Tumor Ablation System t-RFA with the STAR System does not treat cancer. It is cleared by the FDA for providing palliative treatment (e.g. pain relief) by ablation of metastatic malignant tumors in a vertebral body. For a complete list of indications, risks and contraindications, visit http://www.dfineinc.com/Product-Risk—SpineSTAR About DFINE, Inc.DFINE is dedicated to relieving pain and improving the quality of life for patients suffering from spinal diseases through innovative, minimally invasive therapies. The company’s flagship products, the StabiliT® Vertebral Augmentation System and STAR™ Tumor Ablation System, represent generational advancements in the minimally invasive treatment of spinal diseases. DFINE is based in San Jose, Calif. and is a privately held company. DFINE and StabiliT are registered trademarks and STAR and Targeted Radiofrequency Ablation (t-RFA) are trademarks of DFINE, Inc. Media Contact Susan Benton Russell T: 310-697-3488 [email protected]

Merit Medical Supports Utah’s “STEM Curiosity Unleashed” Campaign to Promote Science, Technology, Engineering and Math Education

Merit Medical joined Governor Gary Herbert and other business leaders at a recent news conference to kick off the State’s “STEM Curiosity Unleashed” campaign.

image1-16

Merit and other Utah businesses donated $2.5 million dollars for an advertising campaign to encourage students to study and pursue careers in science, technology, engineering, and math.

The future of companies like Merit Medical depends on more people having a better understanding of science, technology, engineering and mathematics. We support STEM education because the future of our country depends upon it.

We are proud to participate in this effort to educate young people on the value of STEM education and the bright future that STEM careers offer.

image2-19

Merit Laureate Hydrophilic Guide Wire

Merit Laureate® Hydrophilic Guide Wire Available In New 0.018″ Diameter

 

laureatehydrophillicguidewire

AVAILABLE IN NEW 0.018″ DIAMETER

I’m pleased to announce that Merit will be offering a 0.018″ diameter Merit Laureate Hydrophilic Guide Wire worldwide effective February 3, 2014. Smaller diameter guide wires are used in a number of different applications including standard arterial and venous angiography, PTA of chronic total occlusions, thrombolytic therapy, vena cava grams, and endovenous laser ablations.
The Merit Laureate is Merit Medical’s premier hydrophilic guide wire for the placement of devices during diagnostic and interventional procedures in radiology, cardiology, vascular surgery, nephrology, and urology.

THE MERIT LAUREATE OFFERS

  • True 1:1 torque control for greater turn-for-turn responsiveness and rapid vessel selection
  • Reliable and lasting lubricity to minimize surface friction for navigating highly tortuous anatomy and rapid catheter exchanges
  • Enhanced lesion crossability
  • Dependable visualization under fluoroscopy

Available now in 0.018″, 0.025″, 0.035″, and 0.038″ diameters, 80 cm to 260 cm lengths, standard and stiff body, with angled and straight tip configurations. Click here to watch our Merit Laureate Product Demonstration Video with side- by-side comparison to the market leader and a product feature animation.

PENNY GOLDMAN
Senior Product Manager